Reimagining Proteins with AI: Antibodies and Beyond

🌟 Join us for a deep dive into the transformative impact of AI on protein engineering! 🌟
AI has revolutionized areas such as structure prediction, binder and antibody design, developability triage, and sequence optimization. What does this accelerated process mean for the field? A pipeline only moves as fast as its slowest step, and compressing timelines is essential when tackling challenges in protein design.

Join us as we discuss key modalities shaping the current landscape, including antibodies, ADCs, and nanobodies, while looking ahead at future engineered proteins like transcription factors and enzymes. We will assess how AI is optimizing established domains and where it presents new opportunities for research and treatment advancement.

Meet the Speakers:

• Kavita Kulkarni
  Principal PM for AI Research at Biohub, with previous experience at Google Research, where she led scientific collaborations in Biomedical Intelligence and contributed to significant AI tools in the field.
• Nikita Savelyev
  MSAT scientist with 8 years of experience in biologics, specializing in optimizing ADC production.
• Rico Meinl
  Product lead for the applied AI team at Retro Biosciences, working on engineering transcription factors with AI and robotics to enhance human health and lifespan.
• James Lucas
  Associate Director of Computational Protein Generation at Generate:Biomedicines, focusing on scalable approaches for therapeutic discovery through rapid design-build-test-learn cycles.

📍 Location: MBC BioLabs, 135 Mississippi St, San Francisco, CA 94107, USA
🔗 Buy your ticket here!